MedLabs InnoTalk: Cell-based Therapy for Lung Regenerative Medicine & COVID-19

We are thrilled to have Dr.Daniel Weiss with us in our next InnoTalk Event. Dr. Weiss is the Chief Scientific Officer of the International Society for Cell and Gene Therapy (ISCT), as well as the Professor at the University of Vermont School of Medicine. Dr. Weiss has extensive knowledge and experience in lung repair and regeneration after injury, notably gene and cell therapy approaches for lung diseases. Joining as moderator, Dr. Ella Li is the CEO of ZGC Capital and the partner of ZGC U.S. Fund, leading ZGC’s team in investment and healthcare accelerator operation.

In this webinar, Dr. Daniel Weiss will share his vast insights and discuss upcoming advances and opportunities in lung regenerative medicine, as well as the current state of cell-based therapies in delivering therapeutics to the lung and the use of bioengineering approaches to improve drug diseases.

Here is what you will learn:

• Understand current approaches to stem cell-based lung disease therapies, including COVID respiratory failure.
• Understand current advances in bioengineering approaches for lung diseases.
• Understand current approaches to growing new lungs ex vivo for potential use in transplantation
• Understand current approaches for lung support devices/artificial lungs
• Live Q&A Session for all attendees joining the webinar.